Price $20.55 |
Market Cap
239M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
4.78
|
P/S
11.45
|
Dividend %
-
|
|
P/CF
19.1
|
P/FCF
-
|
Op. Cash Flow
-300
|
FCF
0.0
|
|
Op. Margin
-21.00%
|
Net Margin
-18.10%
|
ROE
-11.60%
|
ROI
-5.10%
|
|
ROA
-4.00%
|
EPS Growth
86.30%
|
Current Ratio
6.7
|
Debt/Equity
61.60%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Champions Oncology Inc (CSBR) | $9.48 | - | - | 91.8M | Strong Buy |
| Assertio Therapeutics Inc (ASRT) | $0.83 | - | - | 71.2M | Strong Buy |
| Digirad Corporation (DRAD) | $2.23 | - | - | 6.7M | Strong Buy |
| Plus Therapeutics Inc (PSTV) | $1.73 | - | - | 6.2M | Strong Buy |
| DURECT Corporation (DRRX) | $2.60 | - | - | 417.3M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
